Technologies

Exiris makes use of several platform technologies for target identification and validation. In addition, Exiris is developing its own antibody and drug conjugate technologies: Cancer stem cell platform, Drug conjugate technology and Antibody ID technology.

read more

Services

Exiris provides contract research services and collaborative development agreements using its innovative technology platforms: CSC Platform, Target ID, Drug-Conjugate platform, Custom human mAb production, Biomarker discovery and (…)

read more

Job opportunities

POSTGRADUATE OR YOUNG POSTDOC RESEARCHER IN THE FIRST 4-5 YEARS OF THEIR RESEARCH ACTIVITY

We are looking for a skilled bench scientist with a strong technical background in molecular biology, particularly phage display technologies, to join our Antibody ID Group.

read more
07Oct

Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019

Exiris Human Antibody Phage Display Library for identification of high affinity monoclonal antibodies, without need of further affinity maturation, will be presented at the FOB.. Read More →

Contact us

Exiris srl

Laboratories:
Via Castel Romano 100
00128 Roma RM – Italy

Legal address:
Via Savona 6
00182 Rome – Italy

+39 06 50576530
www.exiris.it
info@exiris.it